申请人:ALLERGAN, INC
公开号:EP0369813A2
公开(公告)日:1990-05-23
The invention provides compounds of the formula (I):
in which:
A is -CH(OCOR₁)CH₂CO-Y, -CH=C(R₂)-R, -CH=CHCO-Z, -CH-C(R₃)-CO₂R; -C≡CR₄, -CH=CH(CH₂)nOX or -CH(OH)CH₂CO-Y; R is C₇-C₁₄ alkyl; R₁ is C₁-C₄ alkyl or NHR₇; R₇ is H, phenyl or C₁-C₄ alkyl; R₂ is halogen or CO₂R₅; R₃ is hydrogen or CO₂H; R₄ is C₇-C₁₄ alkyl, phenyl(CH₂)m, (CH₂)nOX or (CH₂)nCO₂R₅; R₅ is C₁-C₄ alkyl; m is 4-8; n is 7-14; and X is hydrogen, acetyl, PO(OH)₂, CO(CH₂)₃N(R₁)₂ or CO(CH₂)₃N(R₁)₂·HCL or another pharmaceutically acceptable salt; Y is O-C₇-C₁₄ alkyl or NHR₆; Z is C₇-C₁₄ alkyl, morpholine, N-methylpiperazine or NHR₆; and R₆ is C₇-C₁₄ alkyl, phenylethyl, NR₈(CH₂)nN(R₉)₃, NR₈(CH₂)nN(R₉)₃.HCl or NR₈(CH₂)nCO₂H; R₈ is H, C₁-C₃ alkyl; n is 1-8; and R₉ is H or C₁-C₃ alkyl;
pharmaceutical compositions containing them, a process for their preparation, and their use in the treatment of inflammation, an allergic response or psoriasis in a mammal.
本发明提供了式 (I) 的化合物:
其中
A是-CH(OCOR₁)CH₂CO-Y、-CH=C(R₂)-R、-CH=CHCO-Z、-CH-C(R₃)-CO₂R;-C≡CR₄、-CH=CH(CH₂)nOX或-CH(OH)CH₂CO-Y;R是C₇-C₁₄烷基;R₁是C₁-C₄烷基或NHR₇;R₇ 是 H、苯基或 C₁-C₄ 烷基;R₂ 是卤素或 CO₂R₅;R₃ 是氢或 CO₂H;R₄ 是 C₇-C₁₄ 烷基、苯基(CH₂)m、(CH₂)nOX 或 (CH₂)nCO₂R₅;R₅ 是 C₁-C₄ 烷基;m 是 4-8;n 是 7-14;X 是氢、乙酰基、PO(OH)₂、CO(CH₂)₃N(R₁)₂ 或 CO(CH₂)₃N(R₁)₂-HCL 或另一种药学上可接受的盐;Y 是 O-C₇-C₁₄ 烷基或 NHR₆; Z 是 C₇-C₁₄ 烷基、吗啉、N-甲基哌嗪或 NHR₆;以及 R₆ 是 C₇-C₁₄ 烷基、苯乙基、NR₈(CH₂)nN(R₉)₃、NR₈(CH₂)nN(R₉)₃.HCl或NR₈(CH₂)nCO₂H;R₈是H、C₁-C₃烷基;n是1-8;以及R₉是H或C₁-C₃烷基;
含有它们的药物组合物、它们的制备方法以及它们在治疗哺乳动物的炎症、过敏反应或牛皮癣中的用途。